Cary Hsu

741 total citations
27 papers, 392 citations indexed

About

Cary Hsu is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Cary Hsu has authored 27 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Oncology and 13 papers in Epidemiology. Recurrent topics in Cary Hsu's work include Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Cary Hsu is often cited by papers focused on Pancreatic and Hepatic Oncology Research (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers) and Liver Disease Diagnosis and Treatment (8 papers). Cary Hsu collaborates with scholars based in United States and Italy. Cary Hsu's co-authors include Eric J. Silberfein, George Van Buren, Nader N. Massarweh, Hop S. Tran Cao, Nicole Villafañe-Ferriol, Omar Barakat, Rohan Shah, Amy L. McElhany, Kevin P. Shah and Taylor Gilliland and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Nutrients.

In The Last Decade

Cary Hsu

23 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cary Hsu United States 11 269 206 87 85 77 27 392
Masashi Tsunematsu Japan 10 162 0.6× 106 0.5× 64 0.7× 71 0.8× 82 1.1× 68 293
E. Fiona Leitch United Kingdom 7 516 1.9× 200 1.0× 116 1.3× 41 0.5× 75 1.0× 9 626
Amanda C. R. K. Bos Netherlands 10 430 1.6× 200 1.0× 158 1.8× 35 0.4× 23 0.3× 16 563
Myong Hoon Ihn South Korea 11 178 0.7× 149 0.7× 58 0.7× 25 0.3× 19 0.2× 22 312
Ryoga Hamura Japan 11 160 0.6× 122 0.6× 70 0.8× 63 0.7× 72 0.9× 62 313
Yu‐Jen Hsu Taiwan 10 240 0.9× 156 0.8× 92 1.1× 20 0.2× 36 0.5× 38 313
Tsugio Eto Japan 7 191 0.7× 146 0.7× 162 1.9× 40 0.5× 89 1.2× 13 370
Tadashi Uwagawa Japan 11 228 0.8× 175 0.8× 117 1.3× 67 0.8× 49 0.6× 51 384
Yuya Nakamura Japan 10 179 0.7× 120 0.6× 86 1.0× 18 0.2× 45 0.6× 43 305

Countries citing papers authored by Cary Hsu

Since Specialization
Citations

This map shows the geographic impact of Cary Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cary Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cary Hsu more than expected).

Fields of papers citing papers by Cary Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cary Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cary Hsu. The network helps show where Cary Hsu may publish in the future.

Co-authorship network of co-authors of Cary Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Cary Hsu. A scholar is included among the top collaborators of Cary Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cary Hsu. Cary Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erstad, Derek J., Eric J. Silberfein, Cary Hsu, et al.. (2023). Pretreatment Health-Related Quality-of-Life Status and Survival in Pancreatobiliary Surgical Patients. Journal of the American College of Surgeons. 236(4). 861–870. 1 indexed citations
2.
Izzo, Francesco, Eric J. Silberfein, Nader N. Massarweh, et al.. (2022). Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening. Biology. 11(11). 1597–1597. 2 indexed citations
3.
Kutlu, Onur, Eric J. Silberfein, Cary Hsu, et al.. (2022). Factors associated with inability to return to intended oncologic treatment in pancreatic cancer. The American Journal of Surgery. 224(1). 635–640. 3 indexed citations
4.
Menegaz, Brian A., Cary Hsu, Eric J. Silberfein, et al.. (2022). Abstract P3-18-10: Current options and future perspectives for breast margin assessment in clinical practice. Cancer Research. 82(4_Supplement). P3–18.
5.
Vitiello, Gerardo A., Annie Wang, Rachel Lee, et al.. (2021). Surgical resection of early stage hepatocellular carcinoma improves patient survival at safety net hospitals. Journal of Surgical Oncology. 123(4). 963–969. 7 indexed citations
6.
Ryon, Emily L., Joshua P. Kronenfeld, Rachel Lee, et al.. (2020). Surgical management of hepatocellular carcinoma patients with portal vein thrombosis: The United States Safety Net and Academic Center Collaborative Analysis. Journal of Surgical Oncology. 123(2). 407–415. 10 indexed citations
7.
Lee, Rachel, Adriana C. Gamboa, Adam C. Yopp, et al.. (2020). Dissecting disease, race, ethnicity, and socioeconomic factors for hepatocellular carcinoma: An analysis from the United States Safety Net Collaborative. Surgical Oncology. 35. 120–125. 7 indexed citations
8.
Hsu, Cary, et al.. (2020). Demographic and Clinicopathologic Factors of Patients With Hepatocellular Carcinoma in a Safety Net Hospital. Journal of Surgical Research. 256. 374–380. 2 indexed citations
9.
Kronenfeld, Joshua P., Emily L. Ryon, David S. Goldberg, et al.. (2020). Survival inequity in vulnerable populations with early-stage hepatocellular carcinoma: a United States safety-net collaborative analysis. HPB. 23(6). 868–876. 8 indexed citations
10.
Lee, Rachel, Adriana C. Gamboa, Adam C. Yopp, et al.. (2020). Impact of hepatitis C treatment on long-term outcomes for patients with hepatocellular carcinoma: a United States Safety Net Collaborative Study. HPB. 23(3). 422–433. 9 indexed citations
11.
Kronenfeld, Joshua P., Emily L. Ryon, David S. Goldberg, et al.. (2020). Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study. Annals of Surgical Oncology. 28(4). 1929–1936. 12 indexed citations
12.
Villafañe-Ferriol, Nicole, Amy L. McElhany, George Van Buren, et al.. (2019). Evidence Versus Practice in Early Drain Removal After Pancreatectomy. Journal of Surgical Research. 236. 332–339. 15 indexed citations
13.
Shah, Kevin P., George Van Buren, Nicole Villafañe-Ferriol, et al.. (2019). Long-Term Assessment of Pancreatic Function After Pancreatectomy for Cystic Neoplasms. Journal of Surgical Research. 247. 547–555. 11 indexed citations
14.
Villafañe-Ferriol, Nicole, George Van Buren, Amy L. McElhany, et al.. (2018). Sequential drain amylase to guide drain removal following pancreatectomy. HPB. 20(6). 514–520. 13 indexed citations
15.
Cao, Hop S. Tran, George Van Buren, Eric J. Silberfein, et al.. (2018). Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy. Surgery. 165(2). 307–314. 14 indexed citations
16.
Villafañe-Ferriol, Nicole, Amy L. McElhany, Nader N. Massarweh, et al.. (2017). Sequential drain amylase to guide drain removal following pancreatectomy. HPB. 19. S59–S60. 1 indexed citations
17.
Villafañe-Ferriol, Nicole, Amy L. McElhany, Eric J. Silberfein, et al.. (2017). Evidence vs practice in early drain removal following pancreatectomy. HPB. 19. S35–S35. 1 indexed citations
18.
Villafañe-Ferriol, Nicole, Rohan Shah, Somala Mohammed, et al.. (2017). Evidence-Based Management of Drains Following Pancreatic Resection. Pancreas. 47(1). 12–17. 26 indexed citations
19.
Cao, Hop S. Tran, Qianzi Zhang, Yvonne H. Sada, et al.. (2017). Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery. 162(3). 557–567. 31 indexed citations
20.
Hsu, Cary, Susan A. McCloskey, & Parvin F. Peddi. (2016). Management of Breast Sarcoma. Surgical Clinics of North America. 96(5). 1047–1058. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026